Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
David G Levitt & Michael D Levitt. (2014) Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease. Clinical and Experimental Gastroenterology 7, pages 307-328.
Read now
Read now
John VandeBerg & Jeannie Chan. (2012) Hepatobiliary transport in health and disease. Clinical Lipidology 7:2, pages 189-202.
Read now
Read now
Adrian Hill, Natalie Mesens, Margino Steemans, Jinghai James Xu & Michael D. Aleo. (2012) Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metabolism Reviews 44:1, pages 127-140.
Read now
Read now
Ronald PJ Oude Elferink & Ulrich Beuers. (2011) Targeting the ABCB4 gene to control cholesterol homeostasis. Expert Opinion on Therapeutic Targets 15:10, pages 1173-1182.
Read now
Read now
Articles from other publishers (100)
Xue Han, Chuyi Lin, Huijie Liu, Shan Li, Bei Hu & Lei Zhang. (2023) Allocholic acid protects against α‐naphthylisothiocyanate‐induced cholestasis in mice by ameliorating disordered bile acid homeostasis. Journal of Applied Toxicology.
Crossref
Crossref
Hongtao Liu, Rossitza N. Irobalieva, Julia Kowal, Dongchun Ni, Kamil Nosol, Rose Bang-Sørensen, Loïck Lancien, Henning Stahlberg, Bruno Stieger & Kaspar P. Locher. (2023) Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP. Nature Communications 14:1.
Crossref
Crossref
Meng‐ying Chen, Qin Wang, Zhao‐jun Meng, Wei‐jie Men, Ju‐yang Huang, Bin Yu & Kun Zhou. (2023)
Psoralen induces liver injury and affects hepatic bile acids metabolism in female and male
C57BL
/
6J
mice
. Phytotherapy Research 37:6, pages 2280-2289.
Crossref
Crossref
Serat-E Ali, James C Waddington, Adam Lister, Rowena Sison-Young, Robert P Jones, Adeeb H Rehman, Chris E P Goldring, Dean J Naisbitt & Xiaoli Meng. (2023) Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury. Toxicological Sciences 192:1, pages 106-116.
Crossref
Crossref
Giovanni Vitale, Alessandro Mattiaccio, Amalia Conti, Sonia Berardi, Vittoria Vero, Laura Turco, Marco Seri & Maria Cristina Morelli. (2023) Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis. International Journal of Molecular Sciences 24:6, pages 5823.
Crossref
Crossref
Jiaying Lin, Min Li, Wenyao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He & Xiaoqiang Xiang. (2022) Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10:12, pages 788.
Crossref
Crossref
Qi Wang, Hairuo Wen, Shuangcheng Ma & Yujie Zhang. (2022) Polygonum multiflorum Thunb. Induces hepatotoxicity in SD rats and hepatocyte spheroids by Disrupting the metabolism of bilirubin and bile acid. Journal of Ethnopharmacology 296, pages 115461.
Crossref
Crossref
Anna Zerdoug, Marc Le Vée, Shotaro Uehara, Béatrice Lopez, Christophe Chesné, Hiroshi Suemizu & Olivier Fardel. (2022) Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives. European Journal of Drug Metabolism and Pharmacokinetics 47:5, pages 621-637.
Crossref
Crossref
Maria Iuliana Ghenu, Dorin Dragoş, Maria Mirabela Manea, Dorin Ionescu & Lucian Negreanu. (2022) Pathophysiology of sepsis‐induced cholestasis: A review. JGH Open 6:6, pages 378-387.
Crossref
Crossref
Robin Durník, Lenka Šindlerová, Pavel Babica & Ondřej Jurček. (2022) Bile Acids Transporters of Enterohepatic Circulation for Targeted Drug Delivery. Molecules 27:9, pages 2961.
Crossref
Crossref
Jelena Remetic, Ahmed Ghallab, Zaynab Hobloss, Lisa Brackhagen, Reham Hassan, Maiju Myllys, Richard Radun, Veronika Mlitz, Ci Zhu, Maximilian Baumgartner, Waltraud C. Schrottmaier, Marion Mussbacher, Gerald Timelthaler, Hubert Scharnagl, Tatjana Stojakovic, Alice Assinger, Claudia D. Fuchs, Jan G. Hengstler & Michael Trauner. (2022) Loss of bile salt export pump aggravates lipopolysaccharide‐induced liver injury in mice due to impaired hepatic endotoxin clearance. Hepatology 75:5, pages 1095-1109.
Crossref
Crossref
Adrian Po Zhu Li & Dulmini Kariyawasam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
225
243
.
Eliza R. McColl, Vessela Vassileva & Micheline Piquette-Miller. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
608
626
.
Yunzhou Li & Huiping Zhou. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
239
270
.
Lei Zhang, Osatohanmwen J. Enogieru, Sook Wah Yee, Shiew-Mei Huang & Kathleen M. Giacomini. 2022. Atkinson's Principles of Clinical Pharmacology. Atkinson's Principles of Clinical Pharmacology
213
239
.
Hayley Atkinson, Robert Elsby & Philip Butler. 2022. The ADME Encyclopedia. The ADME Encyclopedia
436
447
.
Albert P. Li. 2021. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity
41
77
.
Birk Poller, Felix Huth, Vlasia Kastrinou-Lampou, Gerd A. Kullak-Ublick, Michael Arand & Gian Camenisch. 2021. Transporters and Drug-Metabolizing Enzymes in Drug Toxicity. Transporters and Drug-Metabolizing Enzymes in Drug Toxicity
455
479
.
Anca D. Petrescu & Sharon DeMorrow. (2021) Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury. Cells 10:8, pages 1846.
Crossref
Crossref
Tim Kroll, Martin Prescher, Sander H. J. Smits & Lutz Schmitt. (2020) Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chemical Reviews 121:9, pages 5240-5288.
Crossref
Crossref
Jawaher Abdullah Alamoudi, Wenkuan Li, Nagsen Gautam, Marco Olivera, Jane Meza, Sandeep Mukherjee & Yazen Alnouti. (2021) Bile acid indices as biomarkers for liver diseases I: Diagnostic markers. World Journal of Hepatology 13:4, pages 433-455.
Crossref
Crossref
Saul J. Karpen. 2021. Liver Disease in Children. Liver Disease in Children
26
35
.
Marina Villanueva-Paz, Laura Morán, Nuria López-Alcántara, Cristiana Freixo, Raúl J. Andrade, M Isabel Lucena & Francisco Javier Cubero. (2021) Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants 10:3, pages 390.
Crossref
Crossref
Yi-Shin Huang, Tien-En Chang, Chin-Lin Perng & Yi-Hsiang Huang. (2021) The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia. Journal of the Chinese Medical Association 84:2, pages 129-135.
Crossref
Crossref
Hannes Doerfler, Dana-Adriana Botesteanu, Stefan Blech & Ralf Laux. (2021) Untargeted Metabolomic Analysis Combined With Multivariate Statistics Reveal Distinct Metabolic Changes in GPR40 Agonist-Treated Animals Related to Bile Acid Metabolism. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Jonathan Alvarsson, Staffan Arvidsson McShane, Ulf Norinder & Ola Spjuth. (2021) Predicting With Confidence: Using Conformal Prediction in Drug Discovery. Journal of Pharmaceutical Sciences 110:1, pages 42-49.
Crossref
Crossref
Kristoffer Kjærgaard, Kim Frisch, Michael Sørensen, Ole Lajord Munk, Alan Frederick Hofmann, Jacob Horsager, Anna Christina Schacht, Mary Erickson, David Shapiro & Susanne Keiding. (2021) Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of Hepatology 74:1, pages 58-65.
Crossref
Crossref
Nicola A. Scott, Laura J. Sharpe & Andrew J. Brown. (2021) The E3 ubiquitin ligase MARCHF6 as a metabolic integrator in cholesterol synthesis and beyond. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1866:1, pages 158837.
Crossref
Crossref
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert & Piero Portincasa. 2021. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases
157
177
.
Hayley Atkinson, Robert Elsby & Philip Butler. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
13
.
Jonathan T. Seal, Stephen J. Atkinson, Helen Aylott, Paul Bamborough, Chun-wa Chung, Royston C. B. Copley, Laurie Gordon, Paola Grandi, James R. J. Gray, Lee A. Harrison, Thomas G. Hayhow, Matthew Lindon, Cassie Messenger, Anne-Marie Michon, Darren Mitchell, Alex Preston, Rab K. Prinjha, Inmaculada Rioja, Simon Taylor, Ian D. Wall, Robert J. Watson, James M. Woolven & Emmanuel H. Demont. (2020) The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. Journal of Medicinal Chemistry 63:17, pages 9093-9126.
Crossref
Crossref
Amit S. Kalgutkar. (2019) Designing around Structural Alerts in Drug Discovery. Journal of Medicinal Chemistry 63:12, pages 6276-6302.
Crossref
Crossref
Alexander Jetter & Gerd A. Kullak-Ublick. (2020) Drugs and hepatic transporters: A review. Pharmacological Research 154, pages 104234.
Crossref
Crossref
Guruprasad P. Aithal & Gerd A. Kullak‐Ublick. 2020. The Liver. The Liver
1050
1057
.
Gregory C. Miller & Andrew D. Clouston. (2020) Adult onset of genetic disorders in bile acid transport in the liver. Human Pathology 96, pages 2-7.
Crossref
Crossref
Yujie Yang, Lei Liu, Xiqian Zhang, Xuehua Jiang & Ling Wang. (2019) Tanshinone IIA prevents rifampicin‐induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2. Liver International 40:1, pages 141-154.
Crossref
Crossref
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert & Piero Portincasa. 2020. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases
1
21
.
Martin Prescher, Tim Kroll & Lutz Schmitt. (2019) ABCB4/MDR3 in health and disease – at the crossroads of biochemistry and medicine. Biological Chemistry 400:10, pages 1245-1259.
Crossref
Crossref
Brandy Garzel, Lei Zhang, Shiew-Mei Huang & Hongbing Wang. (2019) A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis. Current Drug Metabolism 20:8, pages 621-632.
Crossref
Crossref
Yayuan Peng, Zengrui Wu, Hongbin Yang, Yingchun Cai, Guixia Liu, Weihua Li & Yun Tang. (2019) Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach. Toxicology Letters 312, pages 22-33.
Crossref
Crossref
Fuhua Yang, Taiki Takeuchi, Koichi Tsuneyama, Tsuyoshi Yokoi & Shingo Oda. (2019) Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats. Toxicological Sciences 170:1, pages 95-108.
Crossref
Crossref
Yutai Li, Raymond Evers, Michael J Hafey, Kyeongmi Cheon, Hong Duong, Donna Lynch, Lisa LaFranco-Scheuch, Stephen Pacchione, Alex M Tamburino, Keith Q Tanis, Kristin Geddes, Daniel Holder, Nanyan Rena Zhang, Wen Kang, Raymond J Gonzalez, Alema Galijatovic-Idrizbegovic, Kara M Pearson, Jose A Lebron, Warren E Glaab & Frank D Sistare. (2019) Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity. Toxicological Sciences 170:1, pages 180-198.
Crossref
Crossref
Tea Omanović Kolarić, Vjera Ninčević, Robert Smolić, Martina Smolić & George Y Wu. (2019) Mechanisms of Hepatic Cholestatic Drug Injury. Journal of Clinical and Translational Hepatology 7:X, pages 1-7.
Crossref
Crossref
Yu Wang, Hong Zhang, Jia-Ming Jiang, Dan Zheng, Yu-Yu Chen, Shi-Jie Wan, Hong-Sheng Tan, Li-Ming Tang & Hong-Xi Xu. (2019) Hepatotoxicity induced by psoralen and isopsoralen from Fructus Psoraleae: Wistar rats are more vulnerable than ICR mice. Food and Chemical Toxicology 125, pages 133-140.
Crossref
Crossref
Guoyu Pan. 2019. Drug Transporters in Drug Disposition, Effects and Toxicity. Drug Transporters in Drug Disposition, Effects and Toxicity
293
340
.
Pieter Van Brantegem, Neel Deferm, Bing Qi, Tom De Vocht & Pieter Annaert. 2019. Experimental Cholestasis Research. Experimental Cholestasis Research
55
73
.
Christiane Guguen-Guillouzo & André Guillouzo. 2019. Experimental Cholestasis Research. Experimental Cholestasis Research
291
312
.
N.M. Bubalo & G.M. Balan. (2018) Syndrome of intrahepatic cholestasis in patients with acute and chronic intoxication with pesticides. Ukrainian Journal of Modern Toxicological Aspects 81:1, pages 39-48.
Crossref
Crossref
Yifan Bao, Xiaochao Ma, Theodore P. Rasmussen & Xiao-bo Zhong. (2018) Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury. Current Pharmacology Reports 4:3, pages 171-181.
Crossref
Crossref
Dániel Szöllősi, Dania Rose-Sperling, Ute A. Hellmich & Thomas Stockner. (2018) Comparison of mechanistic transport cycle models of ABC exporters. Biochimica et Biophysica Acta (BBA) - Biomembranes 1860:4, pages 818-832.
Crossref
Crossref
S. Choudhuri & C.D. Klaassen. 2018. Comprehensive Toxicology. Comprehensive Toxicology
180
220
.
Viktoriia Starokozhko, Rick Greupink, Petra van de Broek, Nashwa Soliman, Samiksha Ghimire, Inge A. M. de Graaf & Geny M. M. Groothuis. (2017) Rat precision-cut liver slices predict drug-induced cholestatic injury. Archives of Toxicology 91:10, pages 3403-3413.
Crossref
Crossref
Bruno Stieger & Zainab M. Mahdi. (2017) Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease. Journal of Pharmaceutical Sciences 106:9, pages 2295-2301.
Crossref
Crossref
Lara Dakhoul & Raj Vuppalanchi. (2017) The Causes and Clinical Spectrum of Drug-Induced Cholestatic Liver Injury. Current Hepatology Reports 16:2, pages 130-136.
Crossref
Crossref
Julia Riede, Birk Poller, Jörg Huwyler & Gian Camenisch. (2017) Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations. Drug Metabolism and Disposition 45:5, pages 523-531.
Crossref
Crossref
Tiffany Cho & Jack Uetrecht. (2016) How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction. Chemical Research in Toxicology 30:1, pages 295-314.
Crossref
Crossref
Claudia D. Fuchs, Gustav Paumgartner, Annika Wahlström, Philipp Schwabl, Thomas Reiberger, Nadja Leditznig, Tatjana Stojakovic, Nataliya Rohr-Udilova, Peter Chiba, Hanns-Ulrich Marschall & Michael Trauner. (2017) Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injury. Journal of Hepatology 66:1, pages 95-101.
Crossref
Crossref
Xiaoxia Gao, Cen Xie, Yuanyuan Wang, Yuhong Luo, Tomoki Yagai, Dongxue Sun, Xuemei Qin, Kristopher W. Krausz & Frank J. Gonzalez. (2016) The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4. Biochemical Pharmacology 119, pages 93-104.
Crossref
Crossref
M. G. Burbank, A. Burban, A. Sharanek, R. J. Weaver, C. Guguen-Guillouzo & A. Guillouzo. (2016) Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis. Drug Metabolism and Disposition 44:11, pages 1780-1793.
Crossref
Crossref
Yaofeng Cheng, Thomas F. Woolf, Jinping Gan & Kan He. (2016) In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review. Chemico-Biological Interactions 255, pages 23-30.
Crossref
Crossref
Zainab M. Mahdi, Uta Synal-Hermanns, Aylin Yoker, Kaspar P. Locher & Bruno Stieger. (2016) Role of Multidrug Resistance Protein 3 in Antifungal-Induced Cholestasis. Molecular Pharmacology 90:1, pages 23-34.
Crossref
Crossref
Oliver Langer. (2016) Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions. The Journal of Clinical Pharmacology 56, pages S143-S156.
Crossref
Crossref
Houfu Liu & Jasminder Sahi. (2016) Role of Hepatic Drug Transporters in Drug Development. The Journal of Clinical Pharmacology 56, pages S11-S22.
Crossref
Crossref
Kaspar P Locher. (2016) Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nature Structural & Molecular Biology 23:6, pages 487-493.
Crossref
Crossref
Ahmad Sharanek, Audrey Burban, Matthew Burbank, Rémy Le Guevel, Ruoya Li, André Guillouzo & Christiane Guguen-Guillouzo. (2016) Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs. Scientific Reports 6:1.
Crossref
Crossref
Yaofeng Cheng, Ayman El-Kattan, Yan Zhang, Adrian S. Ray & Yurong Lai. (2016) Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development. Chemical Research in Toxicology 29:4, pages 545-563.
Crossref
Crossref
Yuanyuan Zhang, Fei Li, Yao Wang, Aaron Pitre, Zhong-ze Fang, Matthew W. Frank, Christopher Calabrese, Kristopher W. Krausz, Geoffrey Neale, Sharon Frase, Peter Vogel, Charles O. Rock, Frank J. Gonzalez & John D. Schuetz. (2015) Maternal bile acid transporter deficiency promotes neonatal demise. Nature Communications 6:1.
Crossref
Crossref
Bruno Stieger & Gerd A. Kullak-Ublick. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety
159
172
.
Antimo Gioiello, Bruno Cerra, Wujuan Zhang, Gian Paolo Vallerini, Gabriele Costantino, Francesca De Franco, Daniela Passeri, Roberto Pellicciari & Kenneth D.R. Setchell. (2014) Synthesis of atypical bile acids for use as investigative tools for the genetic defect of 3?-hydroxy-?5-C27-steroid oxidoreductase deficiency. The Journal of Steroid Biochemistry and Molecular Biology 144, pages 348-360.
Crossref
Crossref
Michael D. Aleo, Yi Luo, Rachel Swiss, Paul D. Bonin, David M. Potter & Yvonne Will. (2014) Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology 60:3, pages 1015-1022.
Crossref
Crossref
Howard R. Mellor. (2014) Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations. Liver International 34:6, pages e1-e9.
Crossref
Crossref
Mikael Persson, Anni F. L?ye, M?lanie Jacquet, Natacha S. Mow, Annemette V. Thougaard, Tomas Mow & Jorrit J. Hornberg. (2014) High-Content Analysis/Screening for Predictive Toxicology: Application to Hepatotoxicity and Genotoxicity. Basic & Clinical Pharmacology & Toxicology 115:1, pages 18-23.
Crossref
Crossref
Christelle Guyot, Lia Hofstetter & Bruno Stieger. (2014)
Differential Effects of Membrane Cholesterol Content on the Transport Activity of Multidrug Resistance–Associated Protein 2 (
ABCC2
) and of the Bile Salt Export Pump (
ABCB11
)
. Molecular Pharmacology 85:6, pages 909-920.
Crossref
Crossref
Anna Baghdasaryan, Peter Chiba & Michael Trauner. (2014) Clinical application of transcriptional activators of bile salt transporters. Molecular Aspects of Medicine 37, pages 57-76.
Crossref
Crossref
Nathan D. PfeiferRhiannon N. HardwickKim L.R. Brouwer. (2014) Role of Hepatic Efflux Transporters in Regulating Systemic and Hepatocyte Exposure to Xenobiotics. Annual Review of Pharmacology and Toxicology 54:1, pages 509-535.
Crossref
Crossref
Beáta Tóth, Péter Krajcsi & Rémi Magnan. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
947
963
.
Ryan E. Morgan, Carlo J. van Staden, Yuan Chen, Natarajan Kalyanaraman, Jackson Kalanzi, Robert T. DunnIIII, Cynthia A. Afshari & Hisham K. Hamadeh. (2013) A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development. Toxicological Sciences 136:1, pages 216-241.
Crossref
Crossref
Eugenia Ulzurrun, Camilla Stephens, Esperanza Crespo, Francisco Ruiz-Cabello, Julia Ruiz-Nuñez, Pablo Saenz-López, Inmaculada Moreno-Herrera, Mercedes Robles-Díaz, Hacibe Hallal, José M. Moreno-Planas, Maria R. Cabello, M. Isabel Lucena & Raúl J. Andrade. (2013) Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury. Liver International 33:9, pages 1378-1385.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
K M Hillgren, D Keppler, A A Zur, K M Giacomini, B Stieger, C E Cass & L Zhang. (2013) Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium. Clinical Pharmacology & Therapeutics 94:1, pages 52-63.
Crossref
Crossref
Bruno Stieger & Gerd A. Kullak‐Ublick. 2013. Pharmacogenomics of Human Drug Transporters. Pharmacogenomics of Human Drug Transporters
295
309
.
Petra Hirsova, Gabriela Karlasova, Eva Dolezelova, Jolana Cermanova, Marie Zagorova, Zuzana Kadova, Milos Hroch, Ludek Sispera, Pavel Tomsik, Martin Lenicek, Libor Vitek, Petr Pavek, Otto Kucera, Zuzana Cervinkova & Stanislav Micuda. (2013) Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology 303, pages 9-15.
Crossref
Crossref
Bruno Stieger & Gerd A. Kullak-Ublick. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
123
133
.
Emese Kis, Enikő Ioja, Zsuzsa Rajnai, Márton Jani, Dóra Méhn, Krisztina Herédi-Szabó & Peter Krajcsi. (2012) BSEP inhibition – In vitro screens to assess cholestatic potential of drugs. Toxicology in Vitro 26:8, pages 1294-1299.
Crossref
Crossref
Carlo J. Staden, Ryan E. Morgan, Bharath Ramachandran, Yuan Chen, Paul H. Lee & Hisham K. Hamadeh. (2012) Membrane Vesicle ABC Transporter Assays for Drug Safety Assessment. Current Protocols in Toxicology 54:1.
Crossref
Crossref
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
335
355
.
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
269
312
.
Kim Frisch, Steen Jakobsen, Michael Sørensen, Ole Lajord Munk, Aage K.O. Alstrup, Peter Ott, Alan F. Hofmann & Susanne Keiding. (2012)
[
N
-Methyl-
11
C]Cholylsarcosine, a Novel Bile Acid Tracer for PET/CT of Hepatic Excretory Function: Radiosynthesis and Proof-of-Concept Studies in Pigs
. Journal of Nuclear Medicine 53:5, pages 772-778.
Crossref
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
159
208
.
Alexander V. LyubimovMark Fielden & Christine Karbowski. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
29
.
Jose J. G. Marin. (2012) Plasma Membrane Transporters in Modern Liver Pharmacology. Scientifica 2012, pages 1-15.
Crossref
Crossref
Paul B. Watkins. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
784
801
.
Eiichiro Ogimura, Shuichi Sekine & Toshiharu Horie. (2011) Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochemical and Biophysical Research Communications 416:3-4, pages 313-317.
Crossref
Crossref
Dongfang Yang, Jian Yang, Deshi Shi, Ruitang Deng & Bingfang Yan. (2011) Scoparone potentiates transactivation of the bile salt export pump gene and this effect is enhanced by cytochrome P450 metabolism but abolished by a PKC inhibitor. British Journal of Pharmacology 164:5, pages 1547-1557.
Crossref
Crossref
Antonia F. Stepan, Daniel P. Walker, Jonathan Bauman, David A. Price, Thomas A. Baillie, Amit S. Kalgutkar & Michael D. Aleo. (2011) Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States. Chemical Research in Toxicology 24:9, pages 1345-1410.
Crossref
Crossref
Bruno Stieger & Peter J Meier. (2011) Pharmacogenetics of drug transporters in the enterohepatic circulation. Pharmacogenomics 12:5, pages 611-631.
Crossref
Crossref
Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar & James L. Boyer. (2011) Drug-induced cholestasis. Hepatology 53:4, pages 1377-1387.
Crossref
Crossref
Chunfang Wang, Xiaojun Chen, Shu-Feng ZhouXiaotian Li. (2011) Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy. Medical Science Monitor 17:5, pages CR265-CR271.
Crossref
Crossref
Bruno Stieger. 2011. Drug Transporters. Drug Transporters
205
259
.
Qi Wang, Hairuo Wen, Shuangcheng ma & Yujie Zhang. (2022) Polygonum Multiflorum Thunb. Induces Hepatotoxicity by Disrupting the Metabolism of Bilirubin and Bile Acid. SSRN Electronic Journal.
Crossref
Crossref